Health care company JRI Orthopaedics has appointed a new chairman.
Frank Collins brings a wealth of experience in the medical devices and orthopaedic sector, having worked for most of his career at senior levels in UK-based healthcare organisations.
He also has significant international experience drawn from his time overseeing divisions and companies in Australia, Germany and France as well as managing commercial relationships with partners in many countries.
“I am delighted to join the JRI Board as its non-executive chairman,” said Mr Collins. “The company is well known as a highly regarded and well established developer and provider of top quality orthopaedic implants and I feel privileged to have been invited to help contribute to its future development.”
JRI Orthopaedics has world-class expertise in the design, development and manufacture of orthopaedic implants and surgical instruments.
Founded on innovation, it was the first company in world orthopedics to produce a hip implant with a Hydroxyapatite coating enabling a biological bond with the patient’s bone and so the prospect of a hip for life.
Innovation remains at the heart of JRI Orthopaedics with an expanding portfolio of products designed with and for surgeons, to help them deliver the best solutions in joint reconstruction, repair and regeneration.
Mr Collins added: “There is little doubt that the company is facing some challenges from an ever-changing and more demanding NHS but I am heartened by the determination across the company to respond positively and effectively to take the company into a new chapter of growth and success.
“This is evident through the recent successes in developing new partnerships in countries such as Brazil and China with the intention of introducing the JRI range to hospitals and patients in those countries and beyond.
“JRI is a UK business that has enormous strengths and qualities; not least its manufacturing competence and deep-rooted commitment to quality which are strong assets for developing overseas markets.”
Last year, the company secured a contract to produce hip replacement implants in its state-of-the-art Sheffield manufacturing facility for a Beijing-based medical company to sell into the Chinese market.
It is also hoping to have its own hip replacement products registered for sale in China this year and has a distribution deal lined up with its Chinese partner.
JRI Orthopaedics is, uniquely, wholly owned by the charity Orthopaedic Research UK (ORUK) and donates its profits to ORUK to fund translational research into bone and joint disease at centres of excellence across the UK.
Mr Collins said: “I have been very impressed with both the wealth of knowledge and the commitment to quality which exist within our modern facility in Sheffield, as well as the clear view that the unique status of the company – given its association with ORUK – really does make it a very special part of British orthopaedic manufacturing.”
He takes over from Brian Jones who has retired after a long career at JRI Orthopaedics, including six years as its Chairman.
JRI Orthopaedics chief executive Keith Jackson said: “The board are delighted that Frank joins us at such an exciting time for JRI. He brings a wealth of experience from medical device companies and from a leading NHS Trust.”